Stocktoria
Sino Green Land Corp. SGLA
Sino Green Land Corp. (SGLA) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.3M at a -135.2% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Wholesale Trade · percentile among 99 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -1.002 |
| Retained earnings / assets | -1.06 |
| EBIT / assets | -0.382 |
| Equity / liabilities | -0.351 |
Detailed pages
Sector peers · similar-size Wholesale Trade companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SGLA | Sino Green Land Corp. | 2/9 | -12.96 | — | — |
| YDDL | One & one Green Technologies. INC | 4/9 | 9.75 | 12.8 | +23.1% |
| POOL | POOL CORP | 5/9 | 4.02 | 19 | -0.4% |
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 35.7 | -1.9% |
| SYY | SYSCO CORP | 5/9 | — | 21.7 | +3.2% |
| PFGC | Performance Food Group Co | 4/9 | 1.92 | 51 | +8.6% |
All Wholesale Trade companies →
FAQ
Is SGLA financially healthy?
Sino Green Land Corp.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does SGLA pay a dividend?
No, Sino Green Land Corp. does not currently pay a dividend.
How profitable is SGLA?
In FY2025, Sino Green Land Corp. had a net margin of -135.2%.
Source: SEC EDGAR filings · CIK 0001433551 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.